Iaterion, Inc.
PrivateLast Round
VC Round
Feb 14, 2024
Total Funding Raised
$298,883
Company Overview
Iaterion, Inc. is a biotechnology company that develops targeted, selective nuclear receptor drugs as alternatives to menopausal hormone therapy for women's health and oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Iaterion, Inc. Comparables
Compare Iaterion, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sermonix Pharmaceuticals | 82% | |
| Azure Biotech, Inc. | 81% | |
| Atossa Therapeutics Inc | 74% | |
Iaterion, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Feb 14, 2024 | ||||
| Grant | Sep 1, 2023 |
Iaterion, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute on Aging | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 14, 2024
Completed a VC Round funding round.
- Sep 1, 2023
$299K grant received from National Institute on Aging.
Iaterion, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Iaterion, Inc.'s valuation, stock price, and market status.